While there is currently no known cure for chronic inflammatory demyelinating polyneuropathy (CIDP), several treatment options can combat the disorder’s symptoms while reducing a patient’s risk of relapse in the future. Here you will find information about four of the most common treatment methods for CIDP.
Like other variants of Guillain-Barre Syndrome (GBS), CIDP is presently incurable. However, treatments can help manage the symptoms of CIDP and reduce the risk of long-term complications. Anyone experiencing the symptoms of CIDP should see a doctor as soon as possible.
The treatment options for individuals diagnosed with CIDP include the following.
While the National Institute of Neurological Disorders and Stroke (NINDS) cautions against steroid treatment for some variants of GBS, it currently recommends corticosteroid treatments as one treatment option for individuals diagnosed with CIDP. Steroids such as prednisone can help reduce the inflammation caused by the body’s autoimmune response and may be prescribed in combination with certain immunosuppressant medications.
Plasmapheresis (Plasma Exchange Therapy)
Plasmapheresis, or plasma exchange therapy, is a treatment option that involves withdrawing blood from a patient’s body and “cleansing” it of antigens and antibodies before injecting it back into the vascular system. These antigens and antibodies reside in the blood’s plasma, which is removed during the process. The body then quickly regenerates plasma upon reintroduction of the cleansed blood cells. While physicians still do not know exactly why plasmapheresis works to treat CIDP, it has repeatedly proven to be an effective treatment option for a wide range of patients.
Immunoglobulin Therapy (Intravenous Immunoglobulin or IVIG)
Immunoglobulin therapy, also known as intravenous immunoglobulin (IVIG), is a treatment that involves injecting a patient with immunoglobulin from blood donors to strengthen the body’s immune system. Similar to plasmapheresis, the goal of IVIG is to combat the body’s autoimmune response to restore the patient’s strength, mobility and normal bodily functions. IVIG typically involves a series of two to four hour-long sessions over a period of several weeks or months.
While not a method for treating the cause of a patient’s symptoms, physiotherapy is typically an important part of the recovery process for individuals diagnosed with CIDP. According to NINDS, “[p]hysiotherapy may improve muscle strength, function and mobility, and minimize the shrinkage of muscles and tendons and distortions of the joints.” Physiotherapy often begins during the initial treatment process (using corticosteroids, plasmapheresis or IVIG) to keep the muscular system functioning, and may be sustained as a long-term treatment for as long as necessary.
Diagnosed with CIDP Following a Vaccination? Call for a Free Consultation
While the physiological cause of CIDP remains unknown, medical experts have identified a link between CIDP and the influenza and tetanus vaccinations. If you or a family member has been diagnosed with CIDP following a vaccination, you may be entitled to financial compensation from the government.
To learn more about the National Vaccine Injury Compensation Program (VICP) and how GBS Vaccine Lawyer can provide legal representation at little or no financial cost to you, please call (202) 775-9200 or request a free consultation online today.